Morningstar DBRS Publishes Updated Global Methodology for Rating Companies in the Pharmaceutical Industry

Morningstar DBRS published an updated version of Global Methodology for Rating Companies in the Pharmaceutical Industry

Morningstar DBRS conducted a periodic review of Global Methodology for Rating Companies in the Pharmaceutical Industry. This update supersedes the previous version published on June 28, 2024 and is effective as of August 9,2024. Morningstar DBRS deems the update not to be material and determined that no ratings are expected to change as a result of this update.

Notes:
Morningstar DBRS methodologies are publicly available on its website dbrs.morningstar.com under Methodologies & Criteria.

For more information on this methodology or on this industry, visit dbrs.morningstar.com or contact us at info-DBRS@morningstar.com.

-- Responsible Analyst(s): Michael Zbinovec, Vikas Munjal
-- Managing Director: Tim O’Brien
-- Group Managing Director: Alan Reid